Company Announcements

Directorate Appointment

Source: RNS
RNS Number : 3564A
Scapa Group PLC
20 January 2020



LEI No. 213800QIPVTK5ES5UU36


20 January 2020



Scapa Group plc

('Scapa' or 'the Company')


Directorate Appointment


Appoints Non-Executive Director with extensive experience across a number of industries, including healthcare


Scapa Group plc (AIM: SCPA) is pleased to announce the appointment of Dr Tim Miller as an Independent Non-Executive Director with effect from 20 January 2020. 


Tim will chair the Remuneration Committee and will also be a member of the Board's Audit and Risk and Nomination Committees. Tim is currently a Non-Executive Director and Remuneration Committee Chair of two FTSE 250 companies: Clarkson plc, the world's leading provider of integrated shipping services, and Equiniti Group plc, an international technology-led services and payments specialist. He is also a Non-Executive Director of Otis Gold Corporation, a resource company listed on the Toronto Stock Exchange.


Larry Pentz, Scapa's Chairman, said:


"On behalf of the Board, I am delighted to welcome Tim to Scapa as a Non-Executive Director. With thirty years' experience across a number of industries, including healthcare, Tim is a highly knowledgeable and experienced Board level executive. As a former Director of Standard Chartered Bank with global responsibility for a variety of functions, he appreciates intimately the current challenges faced by businesses in the UK and overseas. Tim's experience will be invaluable to Scapa as we continue make further progress against our operational and financial objectives through rigorous execution of the strategy."


The Company makes the following disclosures in relation to Tim's appointment in accordance with paragraph (g) of Schedule Two of the AIM Rules for Companies:



Director's full name: Timothy John Miller

Director's age: 63



Current directorships/partnerships:


Name of Company / Partnership

Clarkson plc

Otis Gold Corporation

Equiniti Group plc

Equiniti Financial Services Limited Ltd




Previous directorships/partnerships held during the last five years


Name of Company / Partnership

Academy Concerts Society

Rugby Football Referees Union (National Constituent Body) Ltd

Rugby Football Referees Union Ltd

The Girls' Day School Trust



Shareholding: Dr Miller does not hold any shares in the Company.




Other information: There is no other information required to be disclosed in relation to Dr Miller under paragraph (g) of Schedule Two of the AIM Rules for Companies.






For further information:


Scapa Group plc:

Wendy Baker

Group General Counsel and Company Secretary


+44 (0) 161 301 7400

Numis Securities Limited

(Nominated Adviser and Joint Broker):

Mark Lander

Freddie Barnfield


+44 (0) 20 7260 1000

Berenberg (Joint Broker)

Chris Bowman


+44 (0) 20 3207 7800

FTI Consulting (Media Relations):

Simon Conway

Victoria Foster Mitchell


+44 (0) 20 3727 1000


About Scapa Group plc

Scapa Group plc is a diversified Healthcare and Industrial company focused on bringing best-in-class innovation, design and manufacturing solutions to its customers.



Scapa Healthcare is the trusted strategic partner of choice for the world's leading companies in Advanced Wound Care, Consumer Wellness and Medical Device Fixation. We partner with the top global MedTech companies to develop and manufacture innovative skin friendly medical device fixation and topical solutions, from inception through to market delivery, from our state-of-the-art facilities.


For further information, please visit



Scapa Industrial is a global supplier of bonding solutions and manufacturer of adhesive-based products which offer meaningful value in industrial applications due to their lightweight, easy-to-apply properties. We are recognised for our unparalleled range of products, including adhesive tapes, films and foams, and we can engineer custom designs for even the most unique applications.


For further information, please visit


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit